SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Hansson Karl Johan)
 

Sökning: WFRF:(Hansson Karl Johan) > Anti-Citrullinated ...

  • Westerlind, HelgaKarolinska Institutet,Karolinska Institutet, Stockholm, Sweden (författare)

Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis

  • Artikel/kapitelEngelska2020

Förlag, utgivningsår, omfång ...

  • 2020-09-07
  • John Wiley & Sons,2020
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-423152
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-423152URI
  • https://doi.org/10.1002/art.41381DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:144567051URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Objective To investigate the relationship between anti–citrullinated protein antibodies (ACPAs), specific ACPA subspecificities, rheumatoid factor (RF) isotypes, and incident cardiovascular (CV) events in patients with rheumatoid arthritis (RA).Methods Serum samples from Swedish patients with new-onset RA (diagnosed within 1 year of symptom onset between 1996 and 2009) were centrally typed for anti–cyclic citrullinated peptide 2 (anti-CCP2) antibodies, 20 ACPA subspecificities, and RF isotypes. Patients were followed up longitudinally in nationwide registers to monitor the occurrence of acute coronary syndrome (ACS), stroke, CV-related death, and major adverse CV events (MACE). The association between each serologic marker and CV outcome, and the impact of adjustment for the Disease Activity Score in 28 joints (DAS28), smoking status, and income at baseline, were assessed using Cox proportional hazards models. In addition, associations of serologic markers with all-cause mortality were explored.Results In total, 2,814 patients with RA were included in the study. The median follow-up was 13 years, during which the CV end points of ACS, stroke, or CV-related death were reported to occur in 375 patients. Occurrence and/or levels of anti-CCP2 were associated with risk of incident ACS (hazard ratio [HR] 1.46, 95% confidence interval [95% CI] 1.03–2.06), stroke (HR 1.47, 95% CI 1.03–2.10), CV-related death (P = 0.024 for association with anti-CCP2 levels), and MACE (HR 1.34, 95% CI 1.06–1.70). Similarly, an association with the number of ACPA subspecificities was observed; however, this could not be attributed to any individual or group of ACPA subspecificities. Presence of IgM-RF was associated with all CV end points except ACS, and IgA-RF was exclusively associated with CV-related death. Adjustment for smoking status, income, and DAS28 scores decreased most of the HRs, whereas IgA-RF remained associated with CV-related death (HR 1.61, 95% CI 1.05–2.48). All of the assessed serologic makers were associated with all-cause mortality.Conclusion RF isotypes and ACPAs are associated with future CV events in patients with RA. ACPA levels and number of subspecificities seem more important than the occurrence of particular subspecificities, and these associations were not explained by a history of ever smoking.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Rönnelid, JohanUppsala universitet,Klinisk immunologi,Institutionen för medicinska vetenskaper(Swepub:uu)joharonn (författare)
  • Hansson, MonikaKarolinska Institutet,Karolinska Inst, Stockholm, Sweden; Karolinska Univ Hosp, Stockholm, Sweden (författare)
  • Alfredsson, LarsKarolinska Institutet,Karolinska Institutet, Stockholm, Sweden (författare)
  • Mathsson Alm, LindaUppsala universitet,Klinisk immunologi,Thermo Fisher Sci, Uppsala, Sweden(Swepub:uu)limat990 (författare)
  • Serre, GuyToulouse Univ, Lab Epithelial Differentiat & Rheumatoid Autoimmu, U1056 INSERM, Toulouse, France (författare)
  • Cornillet, MartinToulouse Univ, Lab Epithelial Differentiat & Rheumatoid Autoimmu, U1056 INSERM, Toulouse, France (författare)
  • Holmdahl, RikardKarolinska Institutet,Karolinska Institutet, Stockholm, Sweden (författare)
  • Jakobsson, Per-JohanKarolinska Institutet,Karolinska Inst, Stockholm, Sweden; Karolinska Univ Hosp, Stockholm, Sweden (författare)
  • Skriner, KarlCharité University Hospital, Berlin, Germany (författare)
  • Klareskog, LarsKarolinska Institutet,Karolinska Inst, Stockholm, Sweden; Karolinska Univ Hosp, Stockholm, Sweden (författare)
  • Saevarsdottir, SaedisKarolinska Institutet,Karolinska Inst, Stockholm, Sweden; Univ Iceland, Sch Hlth Sci, Reykjavik, Iceland; Univ Iceland, Fac Med, Reykjavik, Iceland (författare)
  • Askling, JohanKarolinska Institutet,Karolinska Institutet, Stockholm, Sweden (författare)
  • Karolinska InstitutetKarolinska Institutet, Stockholm, Sweden (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Arthritis & Rheumatology: John Wiley & Sons72:10, s. 1658-16672326-51912326-5205

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy